Leading Diagnostic Solutions Company | Nasdaq: BDSX | 2025 & 2024 Top Workplaces Award Winner
Biodesix, Inc. is a leading diagnostic solutions company dedicated to improving clinical care and outcomes for patients. Located in Louisville, Colorado, at its primary address of 919 Dillon Rd, Louisville, Colorado 80027, US, and with an additional location at 8960 Commerce Dr, De Soto, KS 66018, US, Biodesix is at the forefront of innovation in the healthcare sector. Biodesix's diagnostic tests support crucial clinical decisions, expediting personalized care and enhancing outcomes for patients dealing with lung disease.
Biodesix also offers development services, providing biopharmaceutical, life sciences, and research institutions with the scientific, technological, and operational capabilities needed to advance diagnostic tests, tools, and therapeutics. The company's commitment to excellence and impact is evident in its approach to fostering scientific advancements and patient care. With a focus on innovation and precision, Biodesix continues to drive progress in the field of diagnostics.
Biodesix is dedicated to advancing healthcare through cutting-edge diagnostic solutions. The company's ongoing efforts are poised to make significant contributions to the medical field, benefiting patients and healthcare providers alike. Biodesix is actively expanding its reach and influence in the diagnostic market. We invite the manager of Biodesix to create a customized and exclusive company showcase and product listing on our platform, ensuring that Biodesix remains a leader in diagnostic solutions.
Biodesix, Inc. est une société de solutions de diagnostic de premier plan dédiée à l'amélioration des soins cliniques et des résultats pour les patients. Située à Louisville, dans le Colorado, à son adresse principale au 919 Dillon Rd, Louisville, Colorado 80027, États-Unis, et avec un emplacement supplémentaire au 8960 Commerce Dr, De Soto, KS 66018, États-Unis, Biodesix est à l'avant-garde de l'innovation dans le secteur de la santé. Les tests de diagnostic de Biodesix soutiennent les décisions cliniques cruciales, accélérant les soins personnalisés et améliorant les résultats pour les patients atteints de maladies pulmonaires.
Biodesix propose également des services de développement, fournissant aux institutions biopharmaceutiques, des sciences de la vie et de recherche les capacités scientifiques, technologiques et opérationnelles nécessaires pour faire progresser les tests, outils et thérapies de diagnostic. L'engagement de l'entreprise envers l'excellence et l'impact est évident dans son approche visant à favoriser les avancées scientifiques et les soins aux patients. En mettant l'accent sur l'innovation et la précision, Biodesix continue de faire progresser le domaine du diagnostic.
Biodesix se consacre à faire progresser les soins de santé grâce à des solutions de diagnostic de pointe. Les efforts continus de l'entreprise sont sur le point d'apporter des contributions significatives au domaine médical, au profit des patients et des prestataires de soins de santé. Biodesix élargit activement sa portée et son influence sur le marché du diagnostic. Nous invitons le responsable de Biodesix à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme, garantissant ainsi que Biodesix reste un leader dans les solutions de diagnostic.
Compare Biodesix, Inc. with 3 companies in Hospitals-and-Health-Care
| Comparison Field |
Biodesix, Inc.Main Company |
ElyptaView Profile |
GEAGEN HEALTH & BIOT...View Profile |
OncomarkView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2007 | |
|
Company Size
|
— | 11-50 | 2-10 | 11-50 |
|
City
|
Louisville, Colorado | Solna, Stockholm County | ||
|
Country
|
United States | Sweden | ||
|
Skills & Keywords
Comparing with main company
|
29 Total Skills
Diagnostic Solutions
Clinical Care
Lung Disease
Biopharmaceutical
Life Sciences
Diagnostic Tests
Personalized Medicine
oncology
Clinical Trials
lung cancer
lung disease
Biopharma Services
cancer diagnostics
genomics
Prognostic & Mutation Tests
Lung Nodules
Nodule Management
Non-Small Cell Lung Cancer
Mass Spectrometry Analysis of Biological Samples
Molecular Diagnostics
Genomic Testing
liquid biopsy
Proteomics
Predictive
Companion Diagnostics
biomarkers
ddPCR
Artificial Intelligence
multi-omics
|
6 Total
6 Unique
Unique Skills:
cancer
diagnostics
multi-cancer early detection
renal cell carcinoma
systems biology
urology
|
17 Total
17 Unique
Unique Skills:
cancer
cancer diagnosis & monitoring
cancer molecular monitoring
cancer surgery
cancer treatment
genetic
+11
|
5 Total
5 Unique
Unique Skills:
Cancer
ELISA
FISH
IHC
rtPCR
|
Other organizations in the same industry
This company is also known as